首页> 外文期刊>Терапевтичесκий архив >Comparison of the time to analgetic and anti-inflammatory effect in the treatment of gouty arthritis with nimesulide and sodium diclofenac
【24h】

Comparison of the time to analgetic and anti-inflammatory effect in the treatment of gouty arthritis with nimesulide and sodium diclofenac

机译:尼美舒利和双氯芬酸钠治疗痛风性关节炎的止痛和消炎时间比较

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To compare the time to presentation of the analgetic and anti-inflammatory effects of granulated and tablet nimesulide and sodium diclofenac since the start of therapy for gouty arthritis (GA). MATERIAL AND METHODS: Ninety males with gout were randomized into 3 equal groups. The patients were included in the study by the following criteria: a documented diagnosis of gout (Wallace S. criteria), age over 18 years, acute arthritis for less than 3 weeks, affection of 4 and more joints. For 7 days patients of group 1 received nimesil (200 mg/day), those of group 2--aponil (200 mg/day), group 3 --sodium diclofenac (150 mg/day). Swelling, articular, pain indices were estimated daily for 7 days. RESULTS: Patients of group 1 (nimesil) experienced pain relief on min 20; patients taking nimesulide (aponil) experienced pain attenuation within the first hour. Pain (at rest and movement) and the indices declined faster in group 1 than in group 2 as well as in groups 1 and 2 compared to group 3. Arthritis was arrested in 24 (80%) patients of group 1, 11 (36%) of group 2 and 4 (13%) of group 3. CONCLUSION: Efficacy of nimesulide for arrest of an acute gout attack exceeds that of sodium diclofenac. Granulated nimesulide has advantages over tablets. dosage/chemistry/*therapeutic use
机译:目的:比较从开始治疗痛风性关节炎(GA)以来,颗粒状和片剂尼美舒利和双氯芬酸钠的镇痛和抗炎作用的表现时间。材料与方法:将90名患有痛风的男性随机分为3组。通过以下标准将患者纳入研究:痛风的书面诊断(Wallace S.标准),年龄超过18岁,急性关节炎持续3周以内,影响4个及更多关节。第1组的7天患者接受尼美西尔(200 mg /天),第2组-aponil(200 mg /天),第3组的患者双氯芬酸钠(150 mg /天)。每天评估7天的肿胀,关节,疼痛指数。结果:第1组(尼美西尔)患者在第20分钟时疼痛得到缓解;服用尼美舒利(aponil)的患者在第一个小时内疼痛减轻。与第3组相比,第1组的疼痛(静止和运动状态)下降快于第2组以及第1组和第2组。在第1组的24位(80%)患者中,有11名患者(36%)停止了关节炎。 ),第2组的第4步)和第3组的第4项(13%)。结论:尼美舒利对急性痛风发作的抑制作用超过双氯芬酸钠。尼美舒利颗粒优于片剂。剂量/化学/ *治疗用途

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号